Skip to content
healthcare.dev
Get a free key

Bloxiverz

NDC 51754-1200, Neostigmine Methylsulfate, injection, from Exela Pharma Sciences, LLC.

Product NDC
51754-1200
Status
Listed
Labeler
Exela Pharma Sciences, LLC
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA204078
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51754-1200 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEOSTIGMINE METHYLSULFATE1 mg/mL

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
51754-1200-35175412000310 SYRINGE, PLASTIC in 1 CARTON (51754-1200-3) / 5 mL in 1 SYRINGE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d2f55643-2b0d-4ef9-a9d8-b7138b314372

Use it

Look up 51754-1200 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51754-1200 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51754-1200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.